Abnormally high levels of circulating CD34+CD38-, CD34+CD38+, and CD10+ hematopoietic stem and progenitor cells in the peripheral blood of B-Cell chronic lymphocytic leukemia (B-CLL) patients suggest the presence of additional therapeutic target cells

被引：0
|
作者：
Christopherson, Kent W. [1 ,2 ]
Paganessi, Laura A. [1 ]
Rhoades, Darilyn R. [1 ]
Dillon, Hortense M. [1 ]
Gezer, Sefer [1 ]
Larson, Melissa L. [1 ]
Fung, Henry C. [1 ]
Gregory, Stephanie A. [1 ]
机构：
[1] Rush Univ, Med Ctr, Div Hematol Oncol, Sect Hematol & Stem Cell Transplant, Chicago, IL 60612 USA
[2] Rush Univ, Med Ctr, Dept Immunol & Microbiol, Chicago, IL 60612 USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.4711.4711
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4711
引用
收藏
页码：251B / 251B
页数：1
相关论文
共 50 条
  • [1] INTERFERON-GAMMA IS A SPECIFIC INHIBITOR OF VERY PRIMITIVE CD34+CD38- HUMAN HEMATOPOIETIC PROGENITOR CELLS AND NOT OF MORE MATURE CD34+CD38+ PROGENITOR CELLS
    SNOECK, HW
    NYS, G
    LENJOU, M
    LARDON, F
    VANBOCKSTAELE, DR
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 15 - 15
  • [2] Stem cell factor and interleukin 3 receptor expression on CD34+CD38+ and CD34+CD38- cells from umbilical cord blood and mobilized peripheral blood.
    DeBruyn, C
    Delforge, A
    Bron, D
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 735 - 735
  • [3] Comparison of differential microRNA expression profiles between CD34+CD38- and CD34+CD38+ cells in both umbilical cord blood and acute myeloid leukemia.
    Li, Xin
    Zhang, Jiahua
    Liu, Jun
    Huang, Shiang
    BLOOD, 2006, 108 (11) : 146B - 146B
  • [4] Expanded subsets of circulating CD38+T cells in B cell chronic lymphocytic leukemia [B-CLL]
    Bjork, RL
    Mcdaniel, PR
    Saven, A
    Bjork, RL
    CYTOMETRY, 2002, : 107 - 107
  • [5] Phenotyping and Target Expression Profiling of CD34+/CD38- and CD34+/CD38+Stem- and Progenitor cells in Acute Lymphoblastic Leukemia
    Blatt, Katharina
    Menzl, Ingeborg
    Eisenwort, Gregor
    Cerny-Reiterer, Sabine
    Herrmann, Harald
    Herndlhofer, Susanne
    Stefanzl, Gabriele
    Sadovnik, Irina
    Berger, Daniela
    Keller, Alexandra
    Hauswirth, Alexander
    Hoermann, Gregor
    Willmann, Michael
    Rulicke, Thomas
    Sill, Heinz
    Sperr, Wolfgang R.
    Mannhalter, Christine
    Melo, Junia V.
    Jager, Ulrich
    Sexl, Veronika
    Valent, Peter
    NEOPLASIA, 2018, 20 (06): : 632 - 642
  • [6] BONE-MARROW STROMA FROM PATIENTS WITH ACUTE-LEUKEMIA SHOW SELECTIVE REDUCTION IN THE ABILITY TO SUPPORT NORMAL CD34+CD38- CELLS COMPARED TO CD34+CD38+ CELLS
    SPARROW, RL
    OFLAHERTY, E
    BLANKSBY, TM
    SZER, J
    VANDERWEYDEN, MB
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1052 - 1052
  • [7] Characterisation of CD34+CD38+ and CD34+CD38- cells from umbilical cord blood, bone marrow and mobilized peripheral blood before and after stimulation by SCF+IL-3
    De Bruyn, C
    Delforge, A
    Bron, D
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 25 - 25
  • [8] Differentiation of uncommitted human CD34+CD38- cord blood cells into B cell progenitors.
    Cooks, GM
    Quan, S
    Thiemann, FT
    Witte, ON
    Rawlings, DJ
    BLOOD, 1995, 86 (10) : 1672 - 1672
  • [9] Increased content of CD34+CD38- hematopoietic stem cells in the last collected umbilical cord blood
    Malangone, W
    Belvedere, O
    Astori, G
    Adami, V
    Donini, A
    Falasca, E
    Sala, PG
    Del Frate, G
    Pittino, M
    De Anna, D
    Degrassi, A
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1766 - 1768
  • [10] Can CD34+CD38- lymphoblasts, as likely leukemia stem cells, be a prognostic factor in B-cell precursor acute lymphoblastic leukemia in children?
    Stolpa, Weronika
    Mizia-Malarz, Agnieszka
    Zapala, Magdalena
    Zwiernik, Bartosz
    FRONTIERS IN PEDIATRICS, 2023, 11
12345